Acute myeloid leukemia in older adults. - Wikidata - wikimedia - TriplyDB

Acute myeloid leukemia in older adults.

Acute myeloid leukemia in older adults.

http://www.wikidata.org/entity/Q38026008

about

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy Decitabine: a review of its use in older patients with acute myeloid leukaemia.Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia.Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5.The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.Easily manageable prognostic factors in 152 Chinese elderly acute myeloid leukemia patients: a single-center retrospective study.Management of older or unfit patients with acute myeloid leukemia Paraptosis cell death induction by the thiamine analog benfotiamine in leukemia cells Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia AML sensitivity to YM155 is modulated through AKT and Mcl-1.High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.Physician's Attitude Towards Treatment of Older Patients and the Choice of Therapy EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells Atypical breast adenosquamous carcinoma following acute myeloid leukemia in a middle-aged woman: A case report.Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience.CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.TP53 mutations in older adults with acute myeloid leukemia.Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.

P2860

Q26991736-4EBDEDF8-ADA8-45FE-85AC-3BA0B6995295 Q33407030-1C3B44E6-17CB-4E75-A4B0-DF18327A9343 Q33785633-F21E3BA4-74B4-4DAC-84A4-B8ADB9F88C64 Q33907381-CD7127E6-E35D-410A-931F-9C20625FE0E1 Q34171983-950206BA-C53C-4DA6-9686-F2A274C5666A Q34340772-83550141-E72C-4940-B356-7050EBF586FD Q34893307-81043EC3-03AE-4448-ABE6-FD4D80292A07 Q35596628-E8623C70-14FA-4F22-A3F7-CE4E1D14E12E Q35803001-9D5DCDC6-FBE7-44A5-BA66-C17C48F459F8 Q35983805-C5CB6613-2CA9-44F8-BF23-C1A7FBC36649 Q35988637-BE99F227-81F8-4867-AC81-8929205CBF48 Q36826175-C63B474A-DF68-4303-A9C1-42DEB224FCF8 Q37420045-862CC397-EB05-429E-B5C7-83BA253B1236 Q37701764-3D890A34-50C4-4482-8578-5C9A24EB5829 Q38091393-0BFE7318-BE25-440D-92B9-B16F25612E4E Q38248427-67950F6B-D266-40E2-AA23-3E71F1495D5F Q38687484-62189378-3F05-4A61-A5CC-4B802272B73D Q40376093-A46E761D-F8A2-4A00-959C-04E3291F2CD3 Q40967841-9F349AA3-3B92-4E54-8BEF-BAE1278734BB Q41593326-73E707EE-4D41-4DA8-A7BE-83144B5317C4 Q47648441-E9A7344A-3AE0-44A8-9E5E-EC18E226A26B

P2860

Acute myeloid leukemia in older adults.

http://www.wikidata.org/entity/Q38026008

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Acute myeloid leukemia in older adults.

@en

type

label

Acute myeloid leukemia in older adults.

@en

prefLabel

Acute myeloid leukemia in older adults.

@en

P1433

Q38026008-00240C91-D3FF-4146-8096-72B88CF26FF2

P1476

Q38026008-AA63EDE9-E717-409D-83A1-F8B4F416601B

P2093

Q38026008-02F50840-F43C-4108-8D77-F3A1DA2D7C08

Q38026008-6479D162-DE4A-4FDC-918B-CF257B524691

P2860

Q38026008-0629A248-21DB-43ED-8E76-5083D65B29ED

Q38026008-1644527C-D9DF-4C59-ADA5-99D99B6A8103

Q38026008-1AB18721-FCD0-4802-9E75-FE2DC3DD53D6

Q38026008-1AC9749E-62DE-4715-92C3-05F40D6F66CB

Q38026008-1C2F7C3F-1857-4A5A-A616-363E677ADB51

Q38026008-2567C92E-23AE-4344-9BC1-917A104021A8

Q38026008-27EF654A-7171-4AC4-B55A-F53FCC9F610D

Q38026008-29FFEB68-CF89-42CB-A76E-65ED168BB0B7

Q38026008-394015E3-D422-42F0-95D3-73697B4EDD33

Q38026008-41F71942-4B0F-44B5-A110-021778CB517B

P2888

Q38026008-3D0174F1-344E-4CA7-A99E-EF7BFA183CB9

P304

Q38026008-EFD3CC95-4498-445C-B5ED-9E192332A2EB

P31

Q38026008-1ADC8DD0-630B-433A-B255-99E2BE5D6712

P356

Q38026008-5C941469-43A8-4996-974A-AA8E826E62A0

P433

Q38026008-439E195F-AF16-4EEE-9A40-EB35EA06E079

P478

Q38026008-26BC8E9B-A006-443C-8591-29445A4EE54D

P577

Q38026008-54F36779-6FFB-4A6D-AC19-3C0425A1CB7C

P5875

Q38026008-0DF7AD3B-D3F2-4485-B277-B089CC8B7FD8

P6179

Q38026008-115B8C23-BDE9-4D7A-823A-927B9850F120

P698

Q38026008-E439EDE8-1C5B-4AFD-A1CB-8EF24E1BBE93

P921

Q38026008-2BB708F4-FFD4-4CAE-BE03-28BA355D2D01

P356

S12185-012-1137-3

P1433

International Journal of Hematology

P1476

Acute myeloid leukemia in older adults.

@en

P2093

Masamitsu Yanada

http://www.w3.org/2001/XMLSchema#string

Tomoki Naoe

http://www.w3.org/2001/XMLSchema#string

P2860

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

P2888

s12185-012-1137-3

P304

186-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-012-1137-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229082520

http://www.w3.org/2001/XMLSchema#string

P6179

1034073951

http://www.w3.org/2001/XMLSchema#string

P698

22791510

http://www.w3.org/2001/XMLSchema#string

P921